AgingResearch.NewsJoin free

Anti-osteoporosis drugs

Anti-osteoporosis drugs has been studied in 2 papers since 2024: 2 observational studies in people. The newest paper, Jun 1, 2024: “A Multidisciplinary Approach to Hip Fractures: Evaluating Outcomes on Mortality and Secondary Hip Fractures”.

Intervention

2 papers study it1 findingUpdated

See all 2

“This was true both for those without cancer (adjusted HR 0.55; 95% CI 0.51-0.59; P<.0001)”
Anti-osteoporosis drugs reduce mortality in cancer patients: A national cohort study of elderly with vertebral fracturesAnnals of the Academy of Medicine, Singapore2024doi:10.47102/annals-acadmedsg.202396

C, W, M, H: cells, worms or flies, mice, humans. Dark: independent labs found the same change there. Light: one lab or one study. Outline: nothing yet.

  • 1 lab
  • Humans2

What is Anti-osteoporosis drugs linked with?

1

Studies link Anti-osteoporosis drugs with 1 measure, most often mortality (1 study).

Mortality

downin humans1HR 0.55

1 study

  1. Anti-osteoporosis drugs lower the risk of mortality in humans (adjusted HR 0.55 (95% CI 0.51-0.59)).

    “This was true both for those without cancer (adjusted HR 0.55; 95% CI 0.51-0.59; P<.0001)”

    Humanswithout cancern = 5,342

    Anti-osteoporosis drugs reduce mortality in cancer patients: A national cohort study of elderly with vertebral fractures

    Annals of the Academy of Medicine, Singapore

Latest

Related